| Entry |
|
|---|
| Name |
Thiotepa to DNA adducts/cross-links
|
|---|
| Definition |
Thiotepa == DNA |
|---|
| Expanded |
C07641 == C00039 |
|---|
| Class |
nt06250 DNA adduct formation (cancer)
|
|---|
| Type |
Env factor
|
|---|
| Pathway |
| hsa05204 | Chemical carcinogenesis - DNA adducts |
|
|---|
| Disease |
|
|---|
| Perturbant |
|
|---|
| Metabolite |
|
|---|
| Reference |
|
|---|
| Authors |
Maanen MJ, Smeets CJ, Beijnen JH |
|---|
| Title |
Chemistry, pharmacology and pharmacokinetics of N,N',N" -triethylenethiophosphoramide (ThioTEPA). |
|---|
| Journal |
|
|---|
| Reference |
|
|---|
| Authors |
Luch A. |
|---|
| Title |
Nature and nurture - lessons from chemical carcinogenesis. |
|---|
| Journal |
|
|---|
| Reference |
|
|---|
| Authors |
Birkett N, Al-Zoughool M, Bird M, Baan RA, Zielinski J, Krewski D |
|---|
| Title |
Overview of biological mechanisms of human carcinogens. |
|---|
| Journal |
|
|---|
| Reference |
|
|---|
| Authors |
Shah N, Rauenzahn S, Veltri L, Wen S, Craig M, Hamadani M, Kanate AS, Cumpston A |
|---|
| Title |
Long-term outcomes after thiotepa-based high-dose therapy (HDT) and autologous hematopoietic cell transplantation (auto-HCT) in non-Hodgkin lymphoma (NHL). |
|---|
| Journal |
|
|---|
| LinkDB |
|
|---|
